ASSERTIO THERAPEUTICS, INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
ASSERTIO THERAPEUTICS, INC. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $1.68 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-05-10
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $1.68M, a 49.96% increase year-over-year.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-12-31 was $2.82M, a 1.70% increase year-over-year.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-09-30 was $2.17M, a 34.64% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-06-30 was -$100.52M, a 117.76% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was -$94.41M, a 116.37% decline from fiscal 2015.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $576.58M, a 66.06% increase from fiscal 2014.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $347.22M, a 42.37% increase from fiscal 2013.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2013 was $243.88M, a 8979.67% increase from fiscal 2012.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2017-03-31 | $1.68M 10-Q · filed 2017-05-10 | $4.50M derived: sum of 2 quarters · filed 2017-05-10 | $6.67M derived: sum of 3 quarters · filed 2017-05-10 | -$93.85M derived: sum of 4 quarters · filed 2017-05-10 | |
| 2016-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $4.99M derived: sum of 2 quarters · filed 2017-02-24 | -$95.53M derived: sum of 3 quarters · filed 2017-02-24 | -$94.41M 10-K · filed 2017-02-24 | |
| 2016-09-30 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$98.35M derived: sum of 2 quarters · filed 2016-11-07 | -$97.23M 10-Q · filed 2016-11-07 | -$94.46M derived: sum of 4 quarters · filed 2017-05-10 | |
| 2016-06-30 | -$100.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$99.40M 10-Q · filed 2016-08-03 | -$96.63M derived: sum of 3 quarters · filed 2017-05-10 | -$93.31M derived: sum of 4 quarters · filed 2017-05-10 | |
| 2016-03-31 | $1.12M 10-Q · filed 2017-05-10 | $1.58M 10-Q · filed 2016-05-06 | $3.90M derived: sum of 2 quarters · filed 2017-05-10 | $7.21M derived: sum of 3 quarters · filed 2017-05-10 | $573.28M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $6.09M derived: sum of 2 quarters · filed 2017-02-24 | $572.16M derived: sum of 3 quarters · filed 2017-02-24 | $576.58M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $569.39M derived: sum of 2 quarters · filed 2016-11-07 | $573.80M 10-Q · filed 2016-11-07 | $577.20M derived: sum of 4 quarters · filed 2017-02-24 | |
| 2015-06-30 | $566.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $570.48M 10-Q · filed 2016-08-03 | $573.88M derived: sum of 3 quarters · filed 2017-02-24 | $910.63M derived: sum of 4 quarters · filed 2017-02-24 | |
| 2015-03-31 | $4.41M 10-Q · filed 2016-05-06 | $7.81M derived: sum of 2 quarters · filed 2017-02-24 | $344.56M derived: sum of 3 quarters · filed 2017-02-24 | $348.51M derived: sum of 4 quarters · filed 2017-02-24 | |
| 2014-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $340.15M derived: sum of 2 quarters · filed 2017-02-24 | $344.10M derived: sum of 3 quarters · filed 2017-02-24 | $347.22M 10-K · filed 2017-02-24 | |
| 2014-09-30 | $336.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $340.70M derived: sum of 2 quarters · filed 2015-11-09 | $343.82M 10-Q · filed 2015-11-09 | $585.44M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-06-30 | $3.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $7.07M 10-Q · filed 2015-08-03 | $248.69M derived: sum of 3 quarters · filed 2016-02-26 | $249.87M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-03-31 | $3.12M 10-Q · filed 2015-05-11 | $244.74M derived: sum of 2 quarters · filed 2016-02-26 | $245.92M derived: sum of 3 quarters · filed 2016-02-26 | $246.59M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2013-12-31 | $241.62M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $242.80M derived: sum of 2 quarters · filed 2016-02-26 | $243.47M derived: sum of 3 quarters · filed 2016-02-26 | $243.88M 10-K · filed 2016-02-26 | |
| 2013-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.85M derived: sum of 2 quarters · filed 2014-11-06 | $2.26M 10-Q · filed 2014-11-06 | $3.06M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-06-30 | $668.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $1.08M 10-Q · filed 2014-08-06 | $1.88M derived: sum of 3 quarters · filed 2015-02-26 | $2.32M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-03-31 | $408.00K 10-Q · filed 2014-05-09 | $1.21M derived: sum of 2 quarters · filed 2015-02-26 | $1.65M derived: sum of 3 quarters · filed 2015-02-26 | ||
| 2012-12-31 | $801.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $1.25M derived: sum of 2 quarters · filed 2015-02-26 | $2.69M 10-K · filed 2015-02-26 | ||
| 2012-09-30 | $444.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $1.89M 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | $1.44M 10-Q · filed 2013-08-08 | ||||
| 2011-12-31 | $6.05M 10-K · filed 2014-03-17 |